New hope for bladder cancer patients: drug combo tested in early trial
NCT ID NCT04610671
First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 21 times
Summary
This early-phase study tested a combination of two drugs—CG0070 (given directly into the bladder) and nivolumab (given through an IV)—in 21 people with muscle-invasive bladder cancer who could not receive the standard chemotherapy drug cisplatin. The main goal was to check safety and see how well the treatment works before surgery. The study is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.